GRI Bio, Inc. (GRI)

CIK 1824293 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for GRI Bio, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 20268-K0001824293-26-000057
Aug 14, 202610-Q0001824293-26-000055
Aug 13, 2026SCHEDULE 13G/A0001213900-26-088829
Jun 18, 20268-K0001824293-26-000050
May 14, 20268-K0001824293-26-000046
May 13, 2026SCHEDULE 13G/A0001213900-26-055884
May 13, 202610-Q0001824293-26-000044
Feb 13, 2026SCHEDULE 13G/A0001213900-26-016505
Feb 10, 2026SCHEDULE 13G/A0001493152-26-005944
Feb 4, 20268-K0001824293-26-000040
Jan 30, 2026S-80001824293-26-000027
Jan 30, 20268-K0001824293-26-000030
Jan 30, 202610-K0001824293-26-000033
Jan 30, 2026S-30001824293-26-000028
Jan 30, 2026EFFECT9999999995-26-000436
Jan 30, 2026424B50001824293-26-000029
Jan 28, 20268-K0001824293-26-000017
Jan 21, 20268-K0001824293-26-000014
Jan 16, 20268-K0001824293-26-000011
Jan 15, 20268-K0001824293-26-000009
Jan 9, 2026424B50001824293-26-000005
Jan 9, 20268-K0001824293-26-000006
Jan 8, 20268-K0001824293-26-000002
Dec 29, 2025SCHEDULE 13G0001493152-25-029404
Dec 29, 2025DEF 14A0001824293-25-000173